Faster medication increase for heart failure with weak pumping
Part of Heart & circulation clinical trials.
This trial tests a new, faster way to increase heart failure medications during a hospital stay, aiming to get patients on the right doses sooner. It is for people with weak heart pumping (ejection fraction 40% or less) who are currently in the hospital for heart failure and are on low doses of standard medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are currently in the hospital for heart failure with congestion (fluid buildup)
- Your heart's pumping strength (ejection fraction) is 40% or less
- You are only taking small doses of certain heart failure medications (like ACE inhibitors, ARBs, beta-blockers, or MRAs)
- Your blood pressure is above 90 mmHg, heart rate is at least 60 bpm, and potassium levels are normal
- You do not have severe kidney disease, recent heart attack/stroke, or other serious health issues that could affect participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people hospitalized with heart failure and signs of fluid overload, such as swelling or fluid in the lungs. It aims to check if patients still have extra fluid when they go home, which may help improve their recovery.
This study is testing different ways to safely increase the doses of standard heart failure medicines while you are still in the hospital. The goal is to find the best strategy to help your heart work better before you go home.
This trial tests whether adjusting heart failure medications in women can improve their recovery and outcomes. It focuses on women who have been recently hospitalized for acute heart failure and are not yet on optimal medication doses.
This study looks at how well patients with heart failure who have reduced pumping function do when they receive the standard recommended medications. It aims to see short-term improvements in heart function and symptoms.
This trial tests whether safely increasing the dose of standard heart failure medications can improve outcomes in people with a weak heart pump, while keeping a close eye on kidney function. It may be a good fit if you have heart failure with reduced ejection fraction and are not yet on the highest recommended doses of your medicines.
This study tests a personalized approach to safely increase the dose of your heart failure medication (beta-blocker). It aims to improve your symptoms and overall heart function by tailoring the dose to your specific needs.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.